Nemaura Medical Probability of Future Pink Sheet Price Finishing Over 0.48
| NMRDDelisted Stock | USD 0.93 0.01 1.06% |
Nemaura |
Nemaura Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nemaura Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nemaura Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nemaura Medical is not yet fully synchronised with the market data | |
| Nemaura Medical has some characteristics of a very speculative penny stock | |
| Nemaura Medical has a very high chance of going through financial distress in the upcoming years | |
| Nemaura Medical currently holds 20.03 M in liabilities. Nemaura Medical has a current ratio of 0.97, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nemaura Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Nemaura Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nemaura Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nemaura to invest in growth at high rates of return. When we think about Nemaura Medical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 77.04 K. Net Loss for the year was (14.14 M) with loss before overhead, payroll, taxes, and interest of (1.48 M). | |
| Nemaura Medical currently holds about 14.75 M in cash with (8.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.61. | |
| Roughly 48.0% of the company outstanding shares are owned by corporate insiders |
Nemaura Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nemaura Pink Sheet often depends not only on the future outlook of the current and potential Nemaura Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nemaura Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 24.9 M | |
| Cash And Short Term Investments | 10.1 M |
Nemaura Medical Technical Analysis
Nemaura Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Nemaura Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nemaura Medical. In general, you should focus on analyzing Nemaura Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Nemaura Medical Predictive Forecast Models
Nemaura Medical's time-series forecasting models is one of many Nemaura Medical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nemaura Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Nemaura Medical
Checking the ongoing alerts about Nemaura Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nemaura Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Nemaura Medical is not yet fully synchronised with the market data | |
| Nemaura Medical has some characteristics of a very speculative penny stock | |
| Nemaura Medical has a very high chance of going through financial distress in the upcoming years | |
| Nemaura Medical currently holds 20.03 M in liabilities. Nemaura Medical has a current ratio of 0.97, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nemaura Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Nemaura Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nemaura Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nemaura to invest in growth at high rates of return. When we think about Nemaura Medical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 77.04 K. Net Loss for the year was (14.14 M) with loss before overhead, payroll, taxes, and interest of (1.48 M). | |
| Nemaura Medical currently holds about 14.75 M in cash with (8.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.61. | |
| Roughly 48.0% of the company outstanding shares are owned by corporate insiders |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |